 |
|
The effect of salinomycin on ovarian cancer stem-like cells
Hyewon Chung, Yu-Hwan Kim, Myoung Kwon, So-Jin Shin, Sang-Hoon Kwon, Soon-Do Cha, Chi-Heum Cho
Obstet Gynecol Sci. 2016;59(4):261-268. Published online 2016 Jul 13 DOI: https://doi.org/10.5468/ogs.2016.59.4.261
|
|
Citations to this article as recorded by
 Selected markers of ovarian cancer and their relation to targeted therapy (Review)
Anna Markowska, Zbigniew Kojs, Damian Twardawa, Joanna Pietras, Janina Markowska
Experimental and Therapeutic Medicine.2024;[Epub] CrossRef The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease
Oana Gabriela Trifanescu, Raluca Alexandra Trifanescu, Radu Iulian Mitrica, Diana Maria Bran, Georgia Luiza Serbanescu, Laurentiu Valcauan, Serban Andrei Marinescu, Laurentia Nicoleta Gales, Bogdan Cosmin Tanase, Rodica Maricela Anghel
Diagnostics.2023; 13(5): 877. CrossRef The Role of Cancer Stem Cell Markers in Ovarian Cancer
Karolina Frąszczak, Bartłomiej Barczyński
Cancers.2023; 16(1): 40. CrossRef Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska
International Journal of Molecular Sciences.2022; 23(5): 2496. CrossRef Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy
Radhika Narayanaswamy, Vladimir P. Torchilin
Pharmaceutical Research.2021; 38(3): 429. CrossRef The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, Eszter Maka, Judit Szabó, Karen Uray, Zoárd Krasznai, Péter Bai
Molecular Medicine.2021;[Epub] CrossRef Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer
Min Chen, Juan Su, Chunmei Feng, Ying Liu, Li Zhao, Yongjie Tian
Molecular Medicine Reports.2021;[Epub] CrossRef Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, Wojciech Pieńkowski, Katarzyna Stefańska, Paulina Skupin-Mrugalska, Rut Bryl, Paul Mozdziak, Bartosz Kempisty, Hanna Piotrowska-Kempisty
Cancers.2021; 13(16): 4178. CrossRef Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer
Karol Talkowski, Kamil Kiełbasiński, Wojciech Peszek, Beniamin O. Grabarek, Dariusz Boroń, Marcin Oplawski
Current Pharmaceutical Biotechnology.2021; 22(2): 317. CrossRef Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect
Piotr Kras, Karol Talkowski, Beniamin O. Grabarek, Nina Skalska-Dziobek, Dariusz Boroń, Marcin Oplawski
Current Pharmaceutical Biotechnology.2021; 22(5): 697. CrossRef Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study
Marcin Michalak, Michał Stefan Lach, Michał Antoszczak, Adam Huczyński, Wiktoria Maria Suchorska
Molecules.2020; 25(3): 537. CrossRef Yi Qi Jie Du Formula and Salinomycin Combination Treatment Mediates Nasopharyngeal Carcinoma Stem Cell Proliferation, Migration and Apoptosis via CD44/Ras Signaling Pathway
He Lan, Zhou Fang-Liang, Zou Pan, Wang Xian-Wen, Jiang Yi-Lan, He Ying-Chun, Liao Duan-Fang, Cao De-Liang
Digital Chinese Medicine.2020; 3(4): 297. CrossRef Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy
Li Xiaobing, Niu Chunling, Chen Wenyu, Chen Yan, Li Zhenzhen
Current Pharmaceutical Biotechnology.2020; 21(12): 1204. CrossRef The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line
Krzysztof Januszyk, Piotr Januszyk, Beniamin O. Grabarek, Dariusz Boroñ, Marcin Oplawski
Current Pharmaceutical Biotechnology.2020; 21(14): 1505. CrossRef Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
Edith Emmings, Sally Mullany, Zenas Chang, Charles N. Landen, Stig Linder, Martina Bazzaro
International Journal of Molecular Sciences.2019; 20(1): 229. CrossRef Ovarian cancer stem cells and targeted therapy
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad, Mohammad Reza Abbaszadegan
Journal of Ovarian Research.2019;[Epub] CrossRef Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
Vivek Kaushik, Juan Sebastian Yakisich, Anil Kumar, Neelam Azad, Anand K. V. Iyer
Cancers.2018; 10(10): 360. CrossRef Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity
Yingxia Ning, Meng Xu, Xiaocheng Cao, Xiangding Chen, Xin Luo
Oncology Reports.2017; 38(2): 949. CrossRef
|